News
Antioxidants Stimulate Blood Flow in Tumors
The Redox Medicine Society is pleased to welcome Prof. Martin Bergo, Karolinska Institutet, Sweden, to the 26th International Conference "Redox Medicine 2024" this June in Paris.
Prof. Bergo will present how antioxidants can stimulate the blood flow in tumors, while focusing on the activation of BACH1.
You can read more about his findings here.
About Professor Bergo
Martin Bergo serves as the Vice President of Karolinska Institutet. He completed his studies in chemistry and medicine at Umeå University, earning a PhD in medical biochemistry. Following this, he pursued postdoctoral studies at the University of California, San Francisco. In 2004, Bergo established his own research group at the Sahlgrenska Academy, University of Gothenburg, before joining Karolinska Institutet in 2015.
As a professor of molecular medicine, Bergo has a profound interest in fundamental scientific inquiry and understanding disease mechanisms. His research group primarily focuses on investigating various aspects of cancer, such as lung cancer, malignant melanoma, leukemia, and lymphoma. Additionally, they explore inflammatory disorders like atherosclerosis, rheumatoid arthritis, and Hutchinson-Gilford Progeria Syndrome (HGPS), an accelerated aging disorder. Bergo's team conducts curiosity-driven research, often leveraging unexpected discoveries to advance their understanding.
All his team's current research areas stem from a basic interest in an intracellular biochemical signaling pathway that is present in most eukaryotic organisms.
More about Professor Bergo.More about Professor Bergo.
Join Prof. Bergo this June and submit an abstract.
Redox Medicine Society
Redox Medicine 2024 Conference
June 27-28 - Paris, France
Press Releases | Newsletters Archive | LinkedIn
Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia
The Redox Medicine Society is pleased to welcome Prof. Christel Marquette, from the Laboratoire Biosanté U1292 INSERM-CEA-UGA, Equipe MAB2, France, to the 26th International Conference "Redox Medicine 2024" this June in Paris.
Title: Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia
About Prof. Marquette
Christel Marquette is a Research Director at the French Alternative Energies and Atomic Energy Commission (CEA). Her recent research investigates the effects of prokineticins on cerebral cell function and blood-brain barrier permeability, contributing to the understanding of neurovascular interactions and potential therapeutic avenues for neurological disorders.
Redox Medicine 2024 Speaker Line-up.
Redox Medicine Society
Redox Medicine 2024 Conference
June 27-28 - Paris, France
Press Releases | Newsletters Archive | LinkedIn
Epigenetic Modulators Link Mitochondrial Redox Homeostasis to Cardiac Function
The Redox Medicine Society is pleased to welcome Dr. Zaher El Beck, Karolinska Institutet, Sweden, to the 26th International Conference "Redox Medicine 2024" this June in Paris.
Title: Epigenetic Modulators Link Mitochondrial Redox Homeostasis to Cardiac Function in a Sex-Dependent Manner.
Presentation Highlights
- Biological roles of redox, Friends or Foes?
- Why antioxidative treatment for heart failure have failed? Do we need antioxidative treatment?
- Sex dimorphism in the response to oxidative stress and treatments
- Epigenetic modulators link mitochondrial redox homeostasis to cardiac function
Redox Medicine 2024 Speaker Line-up.
Redox Medicine Society
Redox Medicine 2024 Conference
June 27-28 - Paris, France
Press Releases | Newsletters Archive | LinkedIn
Targeting the Keap1/Nrf2 Pathway for Treatment of Chronic Neurodegenerative Diseases
Jeffrey A. Johnson, University of Wisconsin, USA, will join Redox Medicine 2024 this June to give a presentation on his latest research: "Targeting the Keap1/Nrf2 Pathway for Treatment of Chronic Neurodegenerative Diseases".
More information about his findings.
About Jeffrey A. Johnson
Dr. Johnson received a BS in Biology (1984) and MS in Pharmacology (1986) from the University of Minnesota-Duluth, and a PhD in Environmental Toxicology (1992) from the University of Wisconsin. He did postdoctoral training in the Department of Pharmacology at the University of Washington and spent four years as an assistant professor at the University of Kansas Medical Center before joining the University of Wisconsin School of Pharmacy faculty in 1999.
Dr. Johnson is the Director of the Pharmacology and Toxicology BS program. He is also a member of the Waisman Center, Center for Neuroscience, Neuroscience Training Program, Cellular and Molecular Biology Training Program, MD/PhD Training Program, Molecular and Environmental Toxicology Training Program, and Molecular and Cellular Pharmacology Training Program.
His professional interests include transcriptional control of neuroprotective genes and prevention of neurodegeneration in Parkinson's, Alzheimer's, Huntington's and neuromuscular disease.
Join us at Redox Medicine 2024 this June and learn more about strategies targeting redox pathways in neurodegenerative diseases.
Redox Medicine Society
Redox Medicine 2024 Conference
June 27-28 - Paris, France
Press Releases | Newsletters Archive | LinkedIn
Metabolic Regulation by Redox Signaling in the Heart
The Redox Medicine Society is pleased to welcome Dr. Tamara Tomin, TU Wien, Austria, to the 26th International Conference "Redox Medicine 2024" this June in Paris.
Title: Metabolic Regulation by Redox Signaling in the Heart
About Dr. Tomin
Dr. Tomin, having specialized in lipid metabolism in cancer and the role of adipose triglyceride lipase (ATGL), was awarded the HP Kaufman Prize in 2019 for her work in redox analysis, including the development of a novel method for glutathione ratio estimation. Since 2018, she has been a postdoc at the Medical University of Graz and later transitioned to a senior scientist role at TU Wien in 2019, while actively contributing to the Austrian Proteomics and Metabolomics association (APMA) board. She has been exclusively working at TU Wien since October 2019.
Redox Medicine 2024 Speaker Line-up.
Redox Medicine Society
Redox Medicine 2024 Conference
June 27-28 - Paris, France
Press Releases | Newsletters Archive | LinkedIn
More Articles...
- Mechanism of the SuperInflammasome Complexes in Human Diseases and Redox Signaling
- The Reactive Species Interactome, Mitochondria, and the Gender-Brain Metabolism Nexus
- Identifying Oxidized Lipids in Neurodegenerative Diseases
- Redox Implications of Supplementary Oxygen during Major Abdominal Surgery
